Conditions: Glaucoma
Keywords: Glaucoma Trabeculoplasty Selective laser trabeculoplasty Intraocular pressure
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 97
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine whether the choice of post-operative eye drop administered after selective laser trabeculoplasty (SLT) for glaucoma affects the efficacy in lowering intraocular pressure (IOP).

Detailed description:
SLT is used to lower intraocular pressure in glaucoma, but it is not know whether the choice of eyedrops administered in the post-operative period affects SLT efficacy. Practitioners commonly use steroid drops, non-steroidal anti-inflammatory drops, or no drops at all. This is a randomized, single-center, prospective, masked clinical trial to determine whether the choice of eyedrop affects efficacy of SLT in glaucoma patients.

Arms:
arm 1: Topical artificial tears dosed 4 times per day for 4 days in treated eye after laser trabeculoplasty. arm 2: Topical ketorolac 0.5% dosed 4 times per day for 4 days in treated eye after laser trabeculoplasty. arm 3: Topical prednisolone 1% dosed 4 times per day for 4 days in treated eye after laser trabeculoplasty.

Interventions: intervention 1: Prednisolone 1% intervention 2: Ketorolac intervention 3: Artificial Tears
Intervention descriptions: intervention 1: Prednisolone 1% to lasered eye 4 times/day for 4.5 days intervention 2: Ketorolac 0.5% to lasered eye 4 times/day for 4.5 days intervention 3: Artificial saline tears to lasered eye 4 times/day for 4.5 days

Protocol document: